Medicine & Life Sciences
ATP Binding Cassette Transporter, Subfamily B, Member 1
100%
Breast Neoplasms
97%
Multiple Drug Resistance
80%
Neoplasms
79%
Drug Resistance
71%
Cell Line
68%
Proteins
65%
Doxorubicin
65%
MDR Genes
57%
Genes
52%
Fluorouracil
47%
Pharmaceutical Preparations
47%
Irinotecan
47%
ATP Binding Cassette Transporter, Subfamily G, Member 2
44%
Genetic Therapy
40%
Colorectal Neoplasms
36%
Camptothecin
35%
Retroviridae
34%
ATP-Binding Cassette Transporters
32%
K562 Cells
30%
Drug Collateral Sensitivity
30%
Type I DNA Topoisomerase
29%
Orotate Phosphoribosyltransferase
29%
Antineoplastic Agents
29%
Vincristine
29%
Colon
27%
Messenger RNA
27%
Complementary DNA
26%
Tankyrases
26%
Cisplatin
26%
DNA
25%
Clone Cells
25%
Drug Therapy
25%
Leucovorin
24%
Adenocarcinoma
23%
Monoclonal Antibodies
23%
Gefitinib
23%
Heterografts
23%
Internal Ribosome Entry Sites
22%
Lung Neoplasms
22%
Non-Small Cell Lung Carcinoma
22%
arginine ethyl ester
22%
Etoposide
21%
Docetaxel
21%
Mitoxantrone
20%
HCT116 Cells
19%
Growth
19%
Type II DNA Topoisomerase
19%
Down-Regulation
19%
Leukemia
19%
Chemical Compounds
Resistance
63%
Protein
34%
5-Fluorouracil
20%
Antineoplastic Agent
17%
SN-38
16%
Drug
14%
Tamoxifen
12%
Methotrexate
11%
Vincristine
11%
Antitumor
11%
Western Blotting
11%
Tyrosine
10%
Antineoplastic Antibiotic
10%
Complementary DNA
10%
Resazurin
9%
Nocardione A
8%
Flavonoid
8%
Fumitremorgin C
8%
Marker
8%
Mitomycin C
8%
Poly(ADPribose)
8%
Rucaparib
8%
Bleomycin
8%
Mutation
7%
Polypeptide
7%
Cucurbitacin E
7%
Doxorubicin
7%
Tankyrase Inhibitor
7%
Structure-Activity Relationship
7%
Telaprevir
7%
Cytometry
7%
Aurora Kinase Inhibitor
7%
C-1027
7%
Folate
7%
Narirutin
6%
Isocyano Group
6%
Nucleotide
6%
RNA Directed DNA Polymerase Inhibitor
6%
Flavanone Glycoside
6%
Paclitaxel
6%
Metabolite
6%
Carnosic Acid
6%
Aurora
6%
Flavone
6%
Orotate
6%
Stilbenoid
6%
Plasma
6%
Pharmacological Metabolism
6%
Proteasome Inhibitor
5%
Antimitotic
5%